Jennifer Cassels

439 total citations
17 papers, 250 citations indexed

About

Jennifer Cassels is a scholar working on Genetics, Hematology and Molecular Biology. According to data from OpenAlex, Jennifer Cassels has authored 17 papers receiving a total of 250 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Genetics, 10 papers in Hematology and 8 papers in Molecular Biology. Recurrent topics in Jennifer Cassels's work include Chronic Lymphocytic Leukemia Research (8 papers), Chronic Myeloid Leukemia Treatments (8 papers) and Acute Myeloid Leukemia Research (3 papers). Jennifer Cassels is often cited by papers focused on Chronic Lymphocytic Leukemia Research (8 papers), Chronic Myeloid Leukemia Treatments (8 papers) and Acute Myeloid Leukemia Research (3 papers). Jennifer Cassels collaborates with scholars based in United Kingdom, Germany and Egypt. Jennifer Cassels's co-authors include Tessa L. Holyoake, Karen Dunn, David Vetrie, Paolo Gallipoli, Francesca Pellicano, Heather G. Jørgensen, Koorosh Korfi, Lisa Hopcroft, Ross Kinstrie and Mary T. Scott and has published in prestigious journals such as Nature Communications, Blood and Scientific Reports.

In The Last Decade

Jennifer Cassels

15 papers receiving 250 citations

Peers

Jennifer Cassels

HEMAT

MB

GENET

ONCOL

IMMUN

Fanny Fava France

Phillip M. Clair United States

Niklas Landberg Sweden

Shady Adnan Awad Finland

Wanke Zhao United States

Tiago Maié Germany

Nicola Long United States

Parimala Sonika Godavarthy Germany

Edward Kavalerchik United States

Eleni Louka United Kingdom

Fanny Fava France

Jennifer Cassels

129 ×0.8

HEMAT

97 ×1.0

MB

94 ×1.0

GENET

32 ×0.7

ONCOL

21 ×0.5

IMMUN

Citations per year, relative to Jennifer Cassels Jennifer Cassels (= 1×) peers Fanny Fava

Countries citing papers authored by Jennifer Cassels

Since Specialization

Citations

This map shows the geographic impact of Jennifer Cassels's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jennifer Cassels with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jennifer Cassels more than expected).

Fields of papers citing papers by Jennifer Cassels

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jennifer Cassels. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jennifer Cassels. The network helps show where Jennifer Cassels may publish in the future.

Co-authorship network of co-authors of Jennifer Cassels

This figure shows the co-authorship network connecting the top 25 collaborators of Jennifer Cassels. A scholar is included among the top collaborators of Jennifer Cassels based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jennifer Cassels. Jennifer Cassels is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

1.

Hansen, Uwe, Jennifer Cassels, Alison M. Michie, et al.. (2025). The chemical chaperone 4-phenylbutyric acid rescues molecular cell defects of COL3A1 mutations that cause vascular Ehlers Danlos Syndrome. Cell Death Discovery. 11(1). 200–200. 3 indexed citations

2.

Donnelly, Hannah, Ewan A. Ross, Yinbo Xiao, et al.. (2024). Bioengineered niches that recreate physiological extracellular matrix organisation to support long-term haematopoietic stem cells. Nature Communications. 15(1). 5791–5791. 7 indexed citations

3.

Stevens, Thomas, Jennifer Cassels, Claire Schwab, et al.. (2024). Paediatric bone marrow mesenchymal stem cells support acute myeloid leukaemia cell survival and enhance chemoresistance via contact‐independent mechanism. British Journal of Haematology. 206(3). 858–863.

4.

Hay, Jodie, Karen Dunn, Jennifer Cassels, et al.. (2023). mTORC1-selective activation of translation elongation promotes disease progression in chronic lymphocytic leukemia. Leukemia. 37(12). 2414–2425. 7 indexed citations

5.

Hay, Jodie, Anuradha Tarafdar, Karen Dunn, et al.. (2022). PKCβ Facilitates Leukemogenesis in Chronic Lymphocytic Leukaemia by Promoting Constitutive BCR-Mediated Signalling. Cancers. 14(23). 6006–6006. 3 indexed citations

6.

Cassels, Jennifer, et al.. (2022). BH3 mimetics in combination with nilotinib or ponatinib represent a promising therapeutic strategy in blast phase chronic myeloid leukemia. Cell Death Discovery. 8(1). 457–457. 3 indexed citations

7.

Kinstrie, Ross, Gillian A. Horne, Heather Morrison, et al.. (2020). Correction: CD93 is expressed on chronic myeloid leukemia stem cells and identifies a quiescent population which persists after tyrosine kinase inhibitor therapy. Leukemia. 34(7). 1975–1975. 1 indexed citations

8.

Kinstrie, Ross, Gillian A. Horne, Heather Morrison, et al.. (2020). CD93 is expressed on chronic myeloid leukemia stem cells and identifies a quiescent population which persists after tyrosine kinase inhibitor therapy. Leukemia. 34(6). 1613–1625. 50 indexed citations

9.

Dunn, Karen, et al.. (2019). mTORC1 activity is essential for erythropoiesis and B cell lineage commitment. Scientific Reports. 9(1). 16917–16917. 7 indexed citations

10.

Hay, Jodie, et al.. (2019). Subcellular Fractionation of Primary Chronic Lymphocytic Leukemia Cells to Monitor Nuclear/Cytoplasmic Protein Trafficking. Journal of Visualized Experiments. 1 indexed citations

11.

Hay, Jodie, et al.. (2019). Subcellular Fractionation of Primary Chronic Lymphocytic Leukemia Cells to Monitor Nuclear/Cytoplasmic Protein Trafficking. Journal of Visualized Experiments. 1 indexed citations

12.

Scott, Mary T., Koorosh Korfi, Peter Saffrey, et al.. (2016). Epigenetic Reprogramming Sensitizes CML Stem Cells to Combined EZH2 and Tyrosine Kinase Inhibition. Cancer Discovery. 6(11). 1248–1257. 99 indexed citations

13.

Tarafdar, Anuradha, Lisa Hopcroft, Paolo Gallipoli, et al.. (2016). CML cells actively evade host immune surveillance through cytokine-mediated downregulation of MHC-II expression. Blood. 129(2). 199–208. 56 indexed citations

14.

Horne, Gillian A., Heather Morrison, Victoria Campbell, et al.. (2016). Notch Pathway Activation Targets Leukemic Stem Cells in Chronic-Phase Chronic Myeloid Leukemia (CP-CML). Blood. 128(22). 3057–3057. 1 indexed citations

15.

Kinstrie, Ross, Gillian A. Horne, Heather Morrison, et al.. (2015). CD93 Is a Novel Biomarker of Leukemia Stem Cells in Chronic Myeloid Leukemia. Blood. 126(23). 49–49. 10 indexed citations

16.

Abraham, Sheela A., Lisa Hopcroft, Emma Carrick, et al.. (2013). p53 and c-Myc Are Critical Signaling Hubs That Maintain Chronic Myeloid Leukemia. Blood. 122(21). 1465–1465.

17.

Cassels, Jennifer, E. R. Lapwood, J. F. Scott, et al.. (1966). PSP volume 62 issue 1 Cover and Front matter. Mathematical Proceedings of the Cambridge Philosophical Society. 62(1). f1–f4. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact